Puma therapeutics 2025
Puma therapeutics 2025
Puma therapeutics 2025
Puma therapeutics 2025
Puma therapeutics 2025
Puma therapeutics 2025

Puma therapeutics 2025

Puma therapeutics 2025, Puma Biotech Rebranding Alex Maurer Designs 2025

$37.00

SKU: 7323078

Colour
  • 31KB 2001 null null null 3 null null null 1 2003 null m5WIHYEu02FAxM
  • Puma Biotechnology Announces Presentation of Findings from a Phase I II Study of Alisertib and Pembrolizumab for Rb Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR NCI EORTC Molecula...
  • Puma Biotechnology Announces Presentation of Findings from a Phase I II Study of Alisertib and Pembrolizumab for Rb Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR NCI EORTC Molecula...
  • Puma Biotechnology Inc
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus